Analyst firms · J.P. Morgan · MRSN
J.P. Morgan MRSN price target and rating history
Mersana Therapeutics Inc. (MRSN) · Health Care
J.P. Morgan rates Mersana Therapeutics Inc. (MRSN) Neutral with a $5 price target, as of its latest action on Mar 19, 2024. It has published 4 rating actions on MRSN since March 2023, including 2 upgrades and 2 downgrades.
- Current rating
- Neutral
- Price target
- $5
- Median target, all firms
- Too few
- Actions on MRSN
- 4
J.P. Morgan price target on MRSN
Every J.P. Morgan rating on MRSN
- Mar 19, 2024
- Jul 27, 2023
- Jun 16, 2023
- Mar 16, 2023
Questions about J.P. Morgan and MRSN
- What is J.P. Morgan's price target for MRSN?
- J.P. Morgan's latest stated price target for Mersana Therapeutics Inc. (MRSN) is $5, from its action on Mar 19, 2024.
- What is J.P. Morgan's rating on MRSN?
- J.P. Morgan rates MRSN Neutral, a neutral rating, as of Mar 19, 2024.
- When did J.P. Morgan last change its view on MRSN?
- On Mar 19, 2024, J.P. Morgan upgrades to Neutral from Underweight, price target $5.
More MRSN rating histories
All J.P. Morgan ratingsMRSN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.